UBS Group Cuts Envista (NYSE:NVST) Price Target to $27.00

Envista (NYSE:NVST) had its price target reduced by UBS Group from $30.00 to $27.00 in a research report sent to investors on Friday, Marketbeat Ratings reports. UBS Group currently has a neutral rating on the stock.

A number of other equities analysts have also weighed in on the stock. Weiss Ratings upgraded shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 6th. BMO Capital Markets reiterated a “market perform” rating on shares of Envista in a report on Thursday, September 10th. Piper Sandler reiterated a “neutral” rating and issued a $28.00 price target (up from $26.00) on shares of Envista in a research note on Thursday, August 6th. JPMorgan Chase & Co. raised shares of Envista from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $29.00 to $32.00 in a report on Thursday, September 3rd. Finally, Deutsche Bank Aktiengesellschaft set a $32.00 price objective on Envista in a research report on Thursday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.86.

Envista Trading Up 0.1%

NVST stock opened at $23.38 on Friday. Envista has a 1-year low of $18.77 and a 1-year high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. The company has a market capitalization of $3.76 billion, a price-to-earnings ratio of 40.31, a PEG ratio of 1.11 and a beta of 0.86. The business has a 50 day simple moving average of $26.96 and a two-hundred day simple moving average of $26.02.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million during the quarter, compared to analyst estimates of $716.11 million. Envista had a net margin of 3.33% and a return on equity of 7.88%. The company’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the firm posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Research analysts anticipate that Envista will post 1.53 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the sale, the senior vice president owned 27,321 shares of the company’s stock, valued at $751,327.50. This represents a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.99% of the company’s stock.

Institutional Trading of Envista

A number of large investors have recently made changes to their positions in the business. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Envista during the 2nd quarter valued at about $25,000. Allworth Financial LP lifted its holdings in shares of Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares during the last quarter. Nykredit A S purchased a new position in Envista in the second quarter worth about $52,000. IFP Advisors Inc grew its position in Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after acquiring an additional 1,071 shares in the last quarter. Finally, C M Bidwell & Associates Ltd. bought a new stake in Envista during the second quarter worth approximately $63,000.

Key Stories Impacting Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Zacks characterized Envista as technically oversold after a 12% decline over four weeks, suggesting selling pressure may be exhausted. The firm also cited upward earnings-estimate revisions as a possible catalyst for a near-term rebound. Zacks article on buying the dip in Envista
• Positive Sentiment: Piper Sandler reaffirmed its neutral rating but set a $28 price target, implying meaningful upside from the recent trading level. Benzinga analyst rating report
• Positive Sentiment: Additional Zacks commentary highlighted Envista as a potential value stock, which may attract investors following the recent pullback. Zacks value-stock analysis

Envista Company Profile

Envista Holdings Corporation is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral-care professionals.

Envista’s portfolio includes dental imaging and diagnostic systems, digital dentistry and CAD/CAM solutions, dental implants, orthodontic brackets and wires, clear aligner products, endodontic instruments, restorative materials, infection-prevention products and other dental consumables.